Aripiprazole
Product Images NDC 17856-0110
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Aripiprazole (NDC 17856-0110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Atlantic Biologicals Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1: The Effects Of Other Drugs On Aripiprazole Pharmacokinetics (Aripiprazole Fig1)
Figure 2: The Effects Of Other Drugs On Dehydro-aripiprazole Pharmacokinetics (Aripiprazole Fig2)
Figure 3: The Effects Of Aripiprazole On Pharmacokinetics Of Other Drugs (Aripiprazole Fig3)
Figure 4: Effects Of Intrinsic Factors On Aripiprazole Pharmacokinetics (Aripiprazole Fig4)
Figure 5: Effects Of Intrinsic Factors On Dehydro-aripiprazole Pharmacokinetics (Aripiprazole Fig5)
Figure 6: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Relapse (schizophrenia Study 5) (Aripiprazole Fig6)
Figure 7: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Relapse (bipolar Study 7) (Aripiprazole Fig7)
Figure 8: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Relapse To Any Mood Event (bipolar Study 8) (Aripiprazole Fig8)
Image 1 (17856 0110 01 Label 1)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.